"It certainly feels like we are in a recovery phase ... I think and hope that med-tech IPOs will be increasing later this year."

— Richard Gustafson, an investment banker with Piper Jaffray, discussing prospects for an invigorated financing climate for the med-tech sector in the second half of 2009, "WSGR presenters are both hot and cold on future of med-tech funding."